Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
作者信息
Garcia-Bermejo I, Cacho J, Orden B, Alós J I, Gómez-Garcés J L
出版信息
Antimicrob Agents Chemother. 1998 Apr;42(4):989-90. doi: 10.1128/AAC.42.4.989.
Abstract
摘要
相似文献
1
Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
Antimicrob Agents Chemother. 1998 Apr;42(4):989-90. doi: 10.1128/AAC.42.4.989.
2
Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
J Antimicrob Chemother. 2003 Feb;51(2):333-7. doi: 10.1093/jac/dkg100.
3
High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
J Antimicrob Chemother. 2000 May;45(5):605-9. doi: 10.1093/jac/45.5.605.
4
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):25-31. doi: 10.1007/BF01584359.
5
[Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rev Esp Quimioter. 2003 Mar;16(1):61-4.
6
[Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Rev Esp Quimioter. 2003 Mar;16(1):58-60.
7
Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
J Clin Microbiol. 2011 Jan;49(1):439-41. doi: 10.1128/JCM.02208-10. Epub 2010 Nov 10.
8
Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):123-6. doi: 10.1007/s10096-003-1069-1. Epub 2004 Jan 8.
9
[Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Pathol Biol (Paris). 2004 Oct;52(8):489-92. doi: 10.1016/j.patbio.2004.07.032.
10
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
Antimicrob Agents Chemother. 2001 Jan;45(1):339-41. doi: 10.1128/AAC.45.1.339-341.2001.
引用本文的文献
1
[Patient consent to "antimicrobial treatment of tonsillitis"].
Acta Otorrinolaringol Esp. 2003 May;54(5):369-83. doi: 10.1016/s0001-6519(03)78425-8.
2
Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.
Antimicrob Agents Chemother. 2001 Aug;45(8):2375-7. doi: 10.1128/AAC.45.8.2375-2377.2001.
3
Erythromycin resistance in Streptococcus pyogenes in Italy.
Emerg Infect Dis. 2000 Mar-Apr;6(2):180-3. doi: 10.3201/eid0602.000212.
4
Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.
Emerg Infect Dis. 1999 Mar-Apr;5(2):235-40. doi: 10.3201/eid0502.990207.
5
Presence of mefA and mefE genes in Streptococcus agalactiae.
Antimicrob Agents Chemother. 1999 Apr;43(4):944-6. doi: 10.1128/AAC.43.4.944.
6
Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.
Antimicrob Agents Chemother. 1999 Jan;43(1):178-80. doi: 10.1128/AAC.43.1.178.
7
Community acquired infections and bacterial resistance.
BMJ. 1998 Sep 5;317(7159):654-7. doi: 10.1136/bmj.317.7159.654.
本文引用的文献
1
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
Antimicrob Agents Chemother. 1996 Aug;40(8):1817-24. doi: 10.1128/AAC.40.8.1817.
2
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.
Antimicrob Agents Chemother. 1995 Oct;39(10):2239-42. doi: 10.1128/AAC.39.10.2239.
3
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.
Antimicrob Agents Chemother. 1993 Aug;37(8):1717-9. doi: 10.1128/AAC.37.8.1717.
4
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.
J Antimicrob Chemother. 1993 Dec;32(6):885-91. doi: 10.1093/jac/32.6.885.
5
Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.
Eur J Clin Microbiol Infect Dis. 1994 Mar;13(3):238-46. doi: 10.1007/BF01974543.
6
In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics.
Pediatr Infect Dis J. 1994 Jul;13(7):630-5. doi: 10.1097/00006454-199407000-00009.
7
Erythromycin resistance in streptococci.
Lancet. 1989 Aug 19;2(8660):444-5. doi: 10.1016/s0140-6736(89)90618-1.
8
[Antibiotic sensitivity of strains of group A beta-hemolytic streptococci isolated recently].
Med Clin (Barc). 1990 Jan 13;94(1):12-4.
9
Drug resistance in Streptococcus pyogenes isolated in Japan.
Antimicrob Agents Chemother. 1977 Sep;12(3):427-8. doi: 10.1128/AAC.12.3.427.
Zotero 插件